An experimental pill may promise new hope for women with relapsing inflammatory breast cancer, a rare but lethal form of breast cancer that cannot be helped by other treatments.

The pill, Tykerb, attaches itself to two proteins, HER2 and EGFR, which stimulate cancer cells to proliferate and metastasize. The Tykerb blocks the proteins, which slows or stops the growth of cancer tumor cells.

Read about Tykerb at WebMD

Over at our sister site, Brain Boomers, Ellen Weber is giving away the game Brain Age: Train Your Brain in Minutes a Day as a prize for winning the competition she is running. Give it a try – you just might win!

In a recent study, Vitamin D was found to prevent pancreatic cancer by 43% in individuals taking the USRDA of 400 IU daily. Taking 150 IU daily cut the risk of pancreatic cancer by 22%. Taking more than the recommended 400 IU was not found to increase anti-cancer benefits. The study was done by researchers at Northwestern and Harvard universities.

Halcyon Skinner, Ph.D., of Northwestern states “Vitamin D has shown strong potential for preventing and treating prostate cancer, and areas with greater sunlight exposure have lower incidence and mortality for prostate, breast, and colon cancers, leading us to investigate a role for Vitamin D in pancreatic cancer risk.”

Pancreatic cancer is the fourth leading cause of death from cancer in the United States.

Vitamin D May Protect Against Some Cancers